[Productivity, visibility and citation analysis of the Revista Peruana de Medicina Experimental y Salud Pública, 2002-2009.]
Journal Title: Revista Peruana de Medicina Experimental y Salud Publica - Year 2010, Vol 27, Issue 3
Abstract
Biomedical journals are the most used and important venue to disseminate and interchange scientific information, and evaluation is an important component. A bibliometric study was conducted on the productivity, visibility and citation analysis of the Revista Peruana de Medicina Experimental y Salud Pública (RPMESP), from 2002 to 2009. During this period, the RPMESP published about 62 documents per year, 55.3% were research articles. The visibility of RPMESP, determined among three databases (SISBIB-UNMSM, SciELO-Peru, and REDALYC), was irregular, increasing on July 2006, with the highest access on October 2009 (117,618 hits). 43.0% of publications were cited. The calculated impact factor in ISI journals was 0.04 in 2009. In conclusion, the citation of RPMESP shows a slowly growing during the period 2002-2009. It is hoped that the RPMESP increase its visibility and impact after its inclusion in MEDLINE.
Authors and Affiliations
Charles Huamaní
Keywords
Related Articles
- EP ID EP124116
- DOI -
- Views 82
- Downloads 0
Climate change and human health: communicable diseases and Latin America.
Múltiplex-pcr for the diagnosis of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum.
[i]Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum [/i]and [i]Ureaplasma urealyticum [/i]are species related with some pathologies of the urogenital tract, and particularly with non gonococal urethritis (NGU...
Efecto de una intervención educativa sobre higiene alimentaria en escolares de Cajamarca
Incidencia y factores asociados con las reacciones adversas del tratamiento antirretroviral inicial en pacientes con VIH.
La alta incidencia de reacciones adversas medicamentosas (RAMA) al tratamiento antirretroviral de gran actividad (TARGA) en pacientes con VIH/SIDA puede afectar la calidad de vida y adherencia al tratamiento. [b]Objetivo...
Guía para el manejo de pacientes con la nueva Influenza A (H1N1).
Para afrontar la pandemia por la nueva influenza A (H1N1) se requiere de un adecuado manejo de los casos, en ese sentido, la Sociedad Peruana de Enfermedades Infecciosas y Tropicales ha desarrollado una guía que se resum...